Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 340

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 340
---
 to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ Hing C. Wong, Ph.D.
     
    Founder, Chief Executive Officer 
     
     March 28, 2025

    Hing C. Wong, Ph.D.
     
     (Principal Executive Officer)

    /s/ Rebecca Byam
     
     Chief Financial Officer
     
     March 28, 2025

    Rebecca Byam
     
     (Principal Financial and Accounting Officer)

    /s/ Scott T. Garrett 
     
     Chairperson of the Board of Directors 
     
     March 28, 2025

    Scott T. Garrett  

    /s/ Lisa M. Giles
     
     Director 
     
     March 28, 2025

    Lisa M. Giles  

    /s/ Rick S. Greene 
     
     Director
     
     March 28, 2025

    Rick S. Greene 

    /s/ Gary M. Winer
     
     Director
     
     March 28, 2025

    Gary M. Winer  

138